ImpediMed Limited Suite 31C, 12-18 Tryon Rd Lindfield NSW 2070 Australia E: [email protected] W : impedimed.com 27 August 2026 Companies Announcements Office Australian Securities Exchange Appendix 4E – Financial year ended 30 June 2026 ImpediMed...
Appendix 4E
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4e-322
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- FDA Clearance for Sarcopenia Risk Assessment Received
- ASX Listing Rule 7.16 Compliance
- Notification of cessation of securities - IPD
- Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
- Investor Presentation
Later from Impedimed
- 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- Date of 2026 Annual General Meeting
- Update on Options
- Change of Director's Interest Notice - Mr Erik Anderson
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed